Immunogen sequence: the fourth tier of AIDS vaccine design (Q34337482)

1 August 2017

1 reference

title

Immunogen sequence: the fourth tier of AIDS vaccine design (English)

1 reference

1 August 2017

1 reference

1

James I Mullins

1 reference

1 August 2017

5

Gerald H Learn

1 reference

1 August 2017

2

David C Nickle

1 reference

1 August 2017

Laura Heath

3

1 reference

PubMed ID

15285713

1 August 2017

Allen G Rodrigo

series ordinal

4

1 reference

1 August 2017

1 August 2004

1 reference

Expert Review of Vaccines

1 August 2017

1 reference

1 August 2017

3

1 reference

1 August 2017

4 Suppl

1 reference

1 August 2017

S151-9

1 reference

Clinical trials of HIV vaccines.

1 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Antibodies, viruses and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

21 January 2018

HIV vaccine strategies

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Development of a DNA-MVA/HIVA vaccine for Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Diversity considerations in HIV-1 vaccine selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Recreating ancestral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Reconstructing the evolutionary history of the artiodactyl ribonuclease superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Molecules as documents of evolutionary history

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

MRBAYES: Bayesian inference of phylogenetic trees

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Empirical and hierarchical Bayesian estimation of ancestral states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Bayesian inference of phylogeny and its impact on evolutionary biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

HIV vaccine design and the neutralizing antibody problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Medicine. The need for a global HIV vaccine enterprise

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.S151

10.1586/14760584.3.4.S151

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

15285713